Wisst Theresa, Meincke Felix, Spangenberg Tobias, Wienemann Hendrik, Reinholz Claudia, Kreidel Felix, Kuck Karl-Heinz, Ghanem Alexander
Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.
Department of Cardiology, University Hospital Bonn, Bonn, Germany.
AsiaIntervention. 2018 Sep 20;4(2):126-133. doi: 10.4244/AIJ-D-17-00027. eCollection 2018 Sep.
Interventional left atrial appendage closure (LAAC) is routinely performed under both echocardiographic and angiographic guiding. However, adverse outcomes, e.g., kidney injury and cerebral embolism, might be associated with injections of contrast agent into the LAA. Therefore, this prospective registry investigated the safety and feasibility of LAAC without the support of angiographic images as the default approach.
This single-centre registry included a total of 46 non-selected, consecutive patients. In the first 25 patients (54%), LAAC with the Amulet device was performed routinely with LAA angiography prior to implantation and after release of the device. The following 21 patients (46%) were treated without the use of contrast agent. The combination of successful implantation and lack of procedural complications was regarded as the primary endpoint. Procedure time, number of recapture manoeuvres, change of device size, compression, leakage, dose area product and late thrombosis on the device were investigated as secondary endpoints. Besides the longer fluoroscopy time and duration of the procedure in the group using angiography, no significant differences could be found. Major complications occurred equally often in both cohorts.
Interventional LAAC with the Amulet device can be performed safely without the use of contrast agent. This approach might help to enhance the use of LAAC in patients at high risk of contrast-induced nephropathy and procedural stroke.
介入性左心耳封堵术(LAAC)通常在超声心动图和血管造影引导下进行。然而,不良后果,如肾损伤和脑栓塞,可能与向左心耳注射造影剂有关。因此,这项前瞻性注册研究将不使用血管造影图像作为默认方法来探究LAAC的安全性和可行性。
这个单中心注册研究共纳入了46例未经选择的连续患者。前25例患者(54%)在植入Amulet装置前和装置释放后常规进行了左心耳血管造影的LAAC。接下来的21例患者(46%)未使用造影剂进行治疗。成功植入且无手术并发症被视为主要终点。手术时间、重新抓捕操作次数、装置尺寸变化、压缩、渗漏、剂量面积乘积以及装置上的晚期血栓形成作为次要终点进行研究。除了使用血管造影的组中透视时间和手术持续时间更长外,未发现显著差异。两个队列中主要并发症的发生率相同。
使用Amulet装置进行介入性LAAC可以在不使用造影剂的情况下安全进行。这种方法可能有助于增加在有造影剂诱发肾病和手术性卒中高风险患者中LAAC的应用。